Diabetic Therapy
METSIFERâ„¢ VG1
Glimipride 1 mg + Metformin +500 mg + Voglibose 0.3mg.
Dosage Form
Tablets (bi-layered)
Packing
10x15 BLI
(BILAYERED)
(IN O2 SIDE CUT DYE)
MRP
₹1800
Prescribed By
Diabetologist, Endocrinologist, General Physician, Internal Medicine, Family Medicine
Quick Facts
Form
Bi-Layered Tablets
Pack
10×15 Blister
MRP
₹1800
Prescribed By
Diabetologist, Endocrinologist, General Physician
Key Benefits
01
Triple mechanism — insulin stimulation, sensitivity improvement, and post-meal glucose control.
02
Voglibose specifically targets post-meal sugar spikes.
03
Lower Glimepiride dose reduces hypoglycaemia risk.
04
Comprehensive glucose control with three complementary agents.
Mechanism of Action
Glimepiride stimulates insulin secretion. Metformin reduces liver glucose output. Voglibose slows carbohydrate digestion in the gut, reducing post-meal blood sugar spikes. Three complementary mechanisms for comprehensive glucose control.
Indications
Type 2 diabetes with prominent post-meal blood sugar elevation.
Dosage & Administration
Take as prescribed by your doctor or healthcare professional. Do not self-medicate.
Why METSIFERâ„¢ VG1?
METSIFER VG1 is the triple combination for patients where post-meal glucose spikes remain uncontrolled — Voglibose adds crucial post-meal control to the established Glimepiride-Metformin base.
